Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

Metastatic renal cell carcinoma with sarcomatoid histology (SmRCC) is associated with poor survival. No data is available from randomized trials on the efficacy of vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) inhibitors in SmRCC. We identified SmRCC patients fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tantravahi, Srinivas K., Albertson, Daniel, Agarwal, Archana M., Ravulapati, Sowmya, Poole, Austin, Patel, Shiven B., Hawatmeh, Jamil S., Straubhar, Alli M., Liu, Ting, Stenehjem, David D., Agarwal, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320862/
https://www.ncbi.nlm.nih.gov/pubmed/25688268
http://dx.doi.org/10.1155/2015/181926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320862/
https://www.ncbi.nlm.nih.gov/pubmed/25688268
http://dx.doi.org/10.1155/2015/181926

Ejemplares similares